金融界4月22日消息,美因基因因需进一步核实基因检测试剂盒预收款确认收入的合理性及相关推广费用安排,截至2025年3月31日仍未完成必要审计工作,2024年度业绩公告将继续延迟发布,公司股份自2025年4月1日起已暂停买卖,以上数据未经审核。
金融界4月22日消息,美因基因因需进一步核实基因检测试剂盒预收款确认收入的合理性及相关推广费用安排,截至2025年3月31日仍未完成必要审计工作,2024年度业绩公告将继续延迟发布,公司股份自2025年4月1日起已暂停买卖,以上数据未经审核。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.